ev3 Inc. Market Share AnalysisSummaryGlobalData's new report, 'ev3 Inc. Market Share Analysis' provides in-depth information on ev3's market position in the different medical equipment markets it operates in. The report provides ev3's market share information in two key market categories ' Interventional Neurology and Peripheral Vascular Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Scope- Global company shares (in Revenues) information for the key markets ev3 operates in ' Neurology Devices and Cardiovascular Devices.- ev3's company shares (in Revenues) information for all the key countries the company has presence in ' United States, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, and Australia. - ev3's company shares (in Revenues) information for all the key market categories the company has presence in ' Interventional Neurology and Peripheral Vascular Devices.- All the key data-points are for 2009 and cover all the key regions ' North America, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA).- Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries.- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in.- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any ' Mergers & Acquisitions (M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.Reasons to buy- Develop sales and marketing strategies by identifying who-stands-where in the markets, ev3 operates in.- Plan your competition strategies by identifying the company's shares in the markets and geographic regions it operates in.- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to ev3's market positions.
Smartphones: When is the first and last time you check yours?ReportLinker.com
Nearly half (46%) of Americans say they check their smartphones as soon as they wake up, while they’re still in bed, according to ReportLinker’s survey results. This is especially true of Millennials, 66% of whom say it’s the first thing they do before getting out of bed.
75% of Ameircans say they keep their smartphones active all day and night, and a staggering 83% of Millennials say they do.
In fact, disconnecting can be hard. More than half of Americans say their last check is right before bed – and 13% say they disconnect only after they’ve gotten into bed for the night. Even after they fall asleep, about 10% say they’ll wake up and check it during the night.
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoReportLinker.com
ReportLinker and Findout use data analytics technologies to aggregate and normalize data from a wide range of sources to help researchers and analysts find relevant information more efficiently. The companies' core competency lies in both search and data analytics capabilities. Their natural language processing platform analyzes millions of documents daily to extract and structure concepts, relationships, and sentiments to improve users' productivity. Open data initiatives have helped the businesses by providing more content to incorporate, though most value comes from backend processing rather than raw data access. The companies aim to continue enhancing data discovery and contextualization of results.
This graphic shows Samsung's customers are still loyal: 86% of Samsung Customers would consider Samsung next time they upgrade their smartphone. More info on reportlinker.com/inisght
This document provides a summary of a report on the European branded coffee shop market in 23 countries. Some key points:
- It examines the size and growth of the branded coffee shop market in each country from 2009-2015. Several countries like Poland and Spain saw strong growth over 10% in 2011-2012.
- Market leaders like Starbucks, Costa Coffee and Coffee Fellows are profiled for each country along with operating statistics and strategies. Consumer trends toward convenience and sustainability are also discussed.
- Challenges facing the industry like economic uncertainty and high rents are analyzed. Success factors include quality coffee, food offerings and a strong brand. The growth potential of each market is evaluated based on GDP per capita and existing
Allegra's definitive annual study on the UK branded coffee shop market is now available; with insight from over 25,000 consumers the report provides an authoritative view of the market.Drawing on more than 12 years in-depth research, it is considered to be the bible of the coffee sector.KEY AREAS COVERED' Market size and growth projections for the total UK market' Impact of recent economic downturn on trading performance' Key player profiles, including financial performance, pricing analysis and forecasts' Importance of ethical and sustainability issues' Key success factors and market trends' Opportunities and challenges for suppliers' Consumer coffee consumption patterns' Consumer brand awareness and perceptions of key players' Differences between customer demographics, including age, gender, occupation and location by the reportSOURCE OF INFORMATION' Interviews with CEOs, managing directors, senior managers and store managers of major industry players, including:' leading UK coffee and food-focused chains' major coffee roasters and key equipment suppliers' non-specialist players including department stores, supermarkets, bookstores' leading property companies, letting agents and landlords' local authorities' Online surveys with UK coffee shop visitors' Desk research including: News articles and trade press, the Internet and company websites,industry associations, published accounts, data supplied by operators' In-store observations and analysis
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
WinterGreen Research announces that it has published a new study Wireless Infrastructure: Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. Next generation mission critical systems are leveraging new technology. The 2013 study has 554 pages, 245 tables and figures. Worldwide Wireless Infrastructure markets are poised to achieve significant growth as Building out core networks and backhaul for smart phones.A smart phone is not very smart if the infrastructure can't support its applications. In response to the high growth smart phone markets, wireless infrastructure promises to grow dramatically in the near term.. Wireless Infrastructure technologies include WiMax, LTE, 4G and HSPA. These technologies are driving much higher capacity from the base station back to the fiber core. Fiber core is putting extreme pressure on provider's infrastructure and backhaul networks.WinterGreen Research predicts that the dramatic growth of wireless infrastructure is based on the growth of smart phones to a one trillion market by 2019, serving an installed base of 8.5 billion, many people having more than one smart phone. Wireless infrastructure markets at $58 billion in 2012 will be $163 billion by 2019, new markets evolved because of the value that apps provide to smart phones, mobile devices, tablets, and the Internet of things.According to Susan Eustis, lead author of the study, 'Wireless Infrastructure is being installed to upgrade core networks and upgrade backhaul and base stations to make systems more modern. Infrastructure for the Internet and for smart mobile devices creates demand for more sophisticated web development and web applications that in turn depend on more sophisticated infrastructure. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Modern systems represent a significant aspect of Internet market evolution.'The proportions of wireless infrastructure market industry segments are expected to remain much as they are, with the small cells and femtocells achieving strong growth on the access side, the core infrastructure must be upgraded to support the added backhaul backbone infrastructure. Wireless apps are expected to achieve $37 trillion revenue by 2019. This unbelievable growth occurs as the Internet is expanded to implement the interconnection of everything.Digital devices proliferate, machine to machine capabilities vastly expand instrumentation. The digital devices become the engine of a world economy, with apps collecting pennies a day for millions of apps from 8.5 billion people with smart phones by 2019.
Smartphones: When is the first and last time you check yours?ReportLinker.com
Nearly half (46%) of Americans say they check their smartphones as soon as they wake up, while they’re still in bed, according to ReportLinker’s survey results. This is especially true of Millennials, 66% of whom say it’s the first thing they do before getting out of bed.
75% of Ameircans say they keep their smartphones active all day and night, and a staggering 83% of Millennials say they do.
In fact, disconnecting can be hard. More than half of Americans say their last check is right before bed – and 13% say they disconnect only after they’ve gotten into bed for the night. Even after they fall asleep, about 10% say they’ll wake up and check it during the night.
Interview Co-Founder ReportLinker and Findout, Benjamin CarpanoReportLinker.com
ReportLinker and Findout use data analytics technologies to aggregate and normalize data from a wide range of sources to help researchers and analysts find relevant information more efficiently. The companies' core competency lies in both search and data analytics capabilities. Their natural language processing platform analyzes millions of documents daily to extract and structure concepts, relationships, and sentiments to improve users' productivity. Open data initiatives have helped the businesses by providing more content to incorporate, though most value comes from backend processing rather than raw data access. The companies aim to continue enhancing data discovery and contextualization of results.
This graphic shows Samsung's customers are still loyal: 86% of Samsung Customers would consider Samsung next time they upgrade their smartphone. More info on reportlinker.com/inisght
This document provides a summary of a report on the European branded coffee shop market in 23 countries. Some key points:
- It examines the size and growth of the branded coffee shop market in each country from 2009-2015. Several countries like Poland and Spain saw strong growth over 10% in 2011-2012.
- Market leaders like Starbucks, Costa Coffee and Coffee Fellows are profiled for each country along with operating statistics and strategies. Consumer trends toward convenience and sustainability are also discussed.
- Challenges facing the industry like economic uncertainty and high rents are analyzed. Success factors include quality coffee, food offerings and a strong brand. The growth potential of each market is evaluated based on GDP per capita and existing
Allegra's definitive annual study on the UK branded coffee shop market is now available; with insight from over 25,000 consumers the report provides an authoritative view of the market.Drawing on more than 12 years in-depth research, it is considered to be the bible of the coffee sector.KEY AREAS COVERED' Market size and growth projections for the total UK market' Impact of recent economic downturn on trading performance' Key player profiles, including financial performance, pricing analysis and forecasts' Importance of ethical and sustainability issues' Key success factors and market trends' Opportunities and challenges for suppliers' Consumer coffee consumption patterns' Consumer brand awareness and perceptions of key players' Differences between customer demographics, including age, gender, occupation and location by the reportSOURCE OF INFORMATION' Interviews with CEOs, managing directors, senior managers and store managers of major industry players, including:' leading UK coffee and food-focused chains' major coffee roasters and key equipment suppliers' non-specialist players including department stores, supermarkets, bookstores' leading property companies, letting agents and landlords' local authorities' Online surveys with UK coffee shop visitors' Desk research including: News articles and trade press, the Internet and company websites,industry associations, published accounts, data supplied by operators' In-store observations and analysis
Wireless Infrastructure: Market Shares, Strategies, and Forecasts, Worldwide,...ReportLinker.com
WinterGreen Research announces that it has published a new study Wireless Infrastructure: Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2019. Next generation mission critical systems are leveraging new technology. The 2013 study has 554 pages, 245 tables and figures. Worldwide Wireless Infrastructure markets are poised to achieve significant growth as Building out core networks and backhaul for smart phones.A smart phone is not very smart if the infrastructure can't support its applications. In response to the high growth smart phone markets, wireless infrastructure promises to grow dramatically in the near term.. Wireless Infrastructure technologies include WiMax, LTE, 4G and HSPA. These technologies are driving much higher capacity from the base station back to the fiber core. Fiber core is putting extreme pressure on provider's infrastructure and backhaul networks.WinterGreen Research predicts that the dramatic growth of wireless infrastructure is based on the growth of smart phones to a one trillion market by 2019, serving an installed base of 8.5 billion, many people having more than one smart phone. Wireless infrastructure markets at $58 billion in 2012 will be $163 billion by 2019, new markets evolved because of the value that apps provide to smart phones, mobile devices, tablets, and the Internet of things.According to Susan Eustis, lead author of the study, 'Wireless Infrastructure is being installed to upgrade core networks and upgrade backhaul and base stations to make systems more modern. Infrastructure for the Internet and for smart mobile devices creates demand for more sophisticated web development and web applications that in turn depend on more sophisticated infrastructure. Everything is going mobile. This evolution is driven by mobile smart phones and tablets that provide universal connectivity. Modern systems represent a significant aspect of Internet market evolution.'The proportions of wireless infrastructure market industry segments are expected to remain much as they are, with the small cells and femtocells achieving strong growth on the access side, the core infrastructure must be upgraded to support the added backhaul backbone infrastructure. Wireless apps are expected to achieve $37 trillion revenue by 2019. This unbelievable growth occurs as the Internet is expanded to implement the interconnection of everything.Digital devices proliferate, machine to machine capabilities vastly expand instrumentation. The digital devices become the engine of a world economy, with apps collecting pennies a day for millions of apps from 8.5 billion people with smart phones by 2019.
This document is a fax order form for reports from ReportLinker, which provides industry reports, company profiles, and market statistics. It contains fields for customers to provide contact and billing information as well as select a payment method of credit card, wire transfer, or check in order to place an order for reports. The form directs customers to fax the completed form back to ReportLinker offices in either Europe, the Middle East, and Africa or Asia, Oceania, and America depending on location.
This document is a fax order form for industry reports and company profiles from ReportLinker. It contains fields for customers to provide their contact and shipping information as well as payment details including credit card number, expiration date, and CVV. The form also lists ReportLinker's fax numbers for customers in different regions to submit their orders.
This very short document contains a single word - "TEST" - with no other context provided. It is not possible to provide a meaningful summary in 3 sentences or less given the extremely limited information.
Global Electric Resistance Welded Pipes IndustryReportLinker.com
This report analyzes the worldwide markets for Electric Resistance Welded Pipes in Thousand Tons by the following Product Segments: Mechanical Steel Tubing, Structural Tubing, Structural Steel Pipes, Pressure Tubing, Standard Pipes, Oil Country Tubular Goods, and Line Pipes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 181 companies including many key and niche players such as Al Jazeera Steel Products Company SAOG, Arabian Pipes Company, ArcelorMittal SA, ERW Pipes Portfolio of ArcelorMittal ChelPipe, Choo Bee Metal Industries Berhad, EVRAZ North America, JFE Steel Corporation, Maharashtra Seamless Limited, Melewar Industrial Group Berhad, Nippon Steel & Sumitomo Metal Corporation, Northwest Pipe Company, OAO TMK, TMK IPSCO, PT Bakrie Pipe Industries, Salzgitter Mannesmann Line Pipe GmbH, Tata Steel Europe, Techint Group SpA, Tenaris S.A., TenarisSiderca, Ternium S.A., United States Steel Corporation, United Metallurgical Company /OMK, Welspun Corp Ltd., Wheatland Tube Company, and Select Products of Wheatland Tube Company. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
This report analyzes the worldwide markets for Wireless Gaming in US$ Million by the following Product Segments: Messaging Based Wireless Gaming, Browser/Web Based Wireless Gaming, and Downloadable Wireless Gaming. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 90 companies including many key and niche players such as Blockdot, Inc., DeNA Co., Ltd., Electronic Arts, Inc., Gameloft SA,GAMEVIL, GREE International, Inc., Glu Mobile Inc., GigaMedia Limited, HandyGames, I-play, Itsmy
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
Hyperalgesia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Hyperalgesia Global Clinical Trials Review, H1, 2013" provides data on the Hyperalgesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperalgesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperalgesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
Genital Herpes Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Genital Herpes Global Clinical Trials Review, H1, 2013" provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Genital Herpes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
Overview: There are a number of technologies that may be deployed that all provide the ability for devices to "discover" one another, although over different distances ranging from centimeters (Near Field Communications), to meters (Bluetooth), to 10s of meters (Wi-Fi). They also all provide the ability for the devices to communicate directly with one another without a centralized network. Some of these use direct communication as their primary mode of communication e.g. NFC or RFID. Others are more traditional networks which provide direct communication ability as an adjunct to their primary network functions e.g. LTE-Direct or Wi-Fi Direct. Most of the short-term drivers for proximity-based services will be mobile advertising and social networking, especially friend-finder services or dating services, and gaming. In the longer term, other applications will come into play within the scope of the so called Internet of Things. The challenge and opportunity for network operators will be to develop new user scenarios and even new business models to generate revenues from these services. This research uncovers opportunities that will be both beneficial and disruptive to the existing ecosystem and value chain. This research is must reading for any company that is considering offerings within proximity and direct communications and any company that wants to stay ahead of the crowd in terms of preparation for these disruptive technologies. Target Audience: ' Mobile network operators' Industry verticals of all types' Wireless device manufacturers' Network infrastructure companies' Advertising agencies, brands, and merchants' Social networks, advertising, and content providers' Proximity, location, and direct communications vendors Key Report Benefits: ' Market forecasts for each significant technology/solution approach' Recognize the upcoming role and importance of LTE Direct compared to other solutions' Analysis of the major vendors focused on proximity and direct communications solutions' Understand the relationship between proximity, direct communications and the Internet of Things' Understand the technical and business-related differences between proximity/presence and location' Identify each of the major technologies/solutions for proximity detection, location determination, and direct communications' Evaluation of the market for major applications including public safety, social networking, advertising, the Internet of Things, and general location services Select Companies in Report: ' 3M Company' Alcatel-Lucent' iSIGN' LG' Nokia' Samsung' Qualcomm' Verizon Wireless
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
This document provides a summary and table of contents for a 900-page report analyzing the clinical chemistry and immunodiagnostic markets in five major European countries. The report explores trends, evaluates competitors, and identifies opportunities in these evolving markets. It contains estimates of test volumes, sales forecasts by category and country, and competitive profiles of leading suppliers.
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
Bradycardia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Bradycardia Global Clinical Trials Review, H1, 2013" provides data on the Bradycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bradycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bradycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013" provides data on the Acid Indigestion / Heartburn/ Pyrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acid Indigestion / Heartburn/ Pyrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
This document is a report on the China iron ore mining industry in 2013. It provides an overview of the industry, including its definition and development history. It analyzes the macroeconomic environment and discusses factors like policy, upstream/downstream industries. It also examines the international and domestic markets. Key data on the industry from 2008-2012 is presented, including numbers of enterprises, employees, assets, output, sales, profits and trade. The competitive landscape and strategies of major companies are evaluated. The report concludes with discussions of development trends, investment environment and new technologies in the industry.
This document provides a summary and table of contents of the "World Biomass Report" published in November 2012. The report examines the global biomass market and finds that while it suffered during the economic downturn due to low coal prices and supply issues, the sector began growing again in 2010 as coal prices rose. Most biomass plants rely on wood pellets imported from North America, though suppliers from other regions like Russia and Australia aim to compete in the market. The full report contains detailed information on biomass resources, technologies, logistics, investments and policies on a global and national level.
This report provides an overview of the global biofuels industry in 2012. It summarizes production and policies related to first, second, and third generation biofuels in countries around the world. The report finds that 2009 was a difficult year for the biofuels industry due to low oil prices and reduced demand. However, projects using diverse feedstocks or next generation technologies like cellulosics and algae continued to receive investment. The report includes sections on biofuel production trends, technologies, environmental impacts, and policies in regions like Europe, the USA, and individual European countries.
This report analyzes the current state of various renewable energy technologies including hydropower, wind, solar, biomass, biofuels, and geothermal. It examines the market size and outlook for each technology by region, discusses the advantages and disadvantages of different renewable sources, and assesses the development status and future potential of the renewable energy industry globally. The report also profiles major renewable energy companies and evaluates government policies and industry support programs around the world.
This report provides an overview of the global solar photovoltaic (PV) market. It outlines key industry data like global solar capacity, production figures, and forecasts for future growth. It also examines major country markets and discusses the advantages, challenges, and components of the solar PV industry. The report analyzes factors such as government incentives, technology developments, and manufacturing trends that are shaping the future of the solar industry.
Inguinal Hernia Global Clinical Trials Review, H1, 2013ReportLinker.com
Inguinal Hernia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Inguinal Hernia Global Clinical Trials Review, H1, 2013" provides data on the Inguinal Hernia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inguinal Hernia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inguinal Hernia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Cancer Cachexia Global Clinical Trials Review, H1, 2013ReportLinker.com
Cancer Cachexia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Cancer Cachexia Global Clinical Trials Review, H1, 2013" provides data on the Cancer Cachexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cancer Cachexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cancer Cachexia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Pompe Disease Global Clinical Trials Review, H1, 2013ReportLinker.com
This document summarizes a report on clinical trials for Pompe disease from January 2013. It provides an overview of the number and location of trials worldwide in the first half of 2013. The US, Germany, and China had the most trials. The trials were mostly in late phases and investigated drugs from companies like Genzyme and Sanofi. The report analyzed trial trends over time and provided profiles of top trial sponsors.
This document is a fax order form for reports from ReportLinker, which provides industry reports, company profiles, and market statistics. It contains fields for customers to provide contact and billing information as well as select a payment method of credit card, wire transfer, or check in order to place an order for reports. The form directs customers to fax the completed form back to ReportLinker offices in either Europe, the Middle East, and Africa or Asia, Oceania, and America depending on location.
This document is a fax order form for industry reports and company profiles from ReportLinker. It contains fields for customers to provide their contact and shipping information as well as payment details including credit card number, expiration date, and CVV. The form also lists ReportLinker's fax numbers for customers in different regions to submit their orders.
This very short document contains a single word - "TEST" - with no other context provided. It is not possible to provide a meaningful summary in 3 sentences or less given the extremely limited information.
Global Electric Resistance Welded Pipes IndustryReportLinker.com
This report analyzes the worldwide markets for Electric Resistance Welded Pipes in Thousand Tons by the following Product Segments: Mechanical Steel Tubing, Structural Tubing, Structural Steel Pipes, Pressure Tubing, Standard Pipes, Oil Country Tubular Goods, and Line Pipes. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 181 companies including many key and niche players such as Al Jazeera Steel Products Company SAOG, Arabian Pipes Company, ArcelorMittal SA, ERW Pipes Portfolio of ArcelorMittal ChelPipe, Choo Bee Metal Industries Berhad, EVRAZ North America, JFE Steel Corporation, Maharashtra Seamless Limited, Melewar Industrial Group Berhad, Nippon Steel & Sumitomo Metal Corporation, Northwest Pipe Company, OAO TMK, TMK IPSCO, PT Bakrie Pipe Industries, Salzgitter Mannesmann Line Pipe GmbH, Tata Steel Europe, Techint Group SpA, Tenaris S.A., TenarisSiderca, Ternium S.A., United States Steel Corporation, United Metallurgical Company /OMK, Welspun Corp Ltd., Wheatland Tube Company, and Select Products of Wheatland Tube Company. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
This report analyzes the worldwide markets for Wireless Gaming in US$ Million by the following Product Segments: Messaging Based Wireless Gaming, Browser/Web Based Wireless Gaming, and Downloadable Wireless Gaming. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. The report profiles 90 companies including many key and niche players such as Blockdot, Inc., DeNA Co., Ltd., Electronic Arts, Inc., Gameloft SA,GAMEVIL, GREE International, Inc., Glu Mobile Inc., GigaMedia Limited, HandyGames, I-play, Itsmy
Hyperalgesia Global Clinical Trials Review, H1, 2013ReportLinker.com
Hyperalgesia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Hyperalgesia Global Clinical Trials Review, H1, 2013" provides data on the Hyperalgesia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperalgesia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperalgesia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Genital Herpes Global Clinical Trials Review, H1, 2013ReportLinker.com
Genital Herpes Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Genital Herpes Global Clinical Trials Review, H1, 2013" provides data on the Genital Herpes clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Genital Herpes. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Genital Herpes. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
The Future of Direct Communications Technologies and Proximity-based Applicat...ReportLinker.com
Overview: There are a number of technologies that may be deployed that all provide the ability for devices to "discover" one another, although over different distances ranging from centimeters (Near Field Communications), to meters (Bluetooth), to 10s of meters (Wi-Fi). They also all provide the ability for the devices to communicate directly with one another without a centralized network. Some of these use direct communication as their primary mode of communication e.g. NFC or RFID. Others are more traditional networks which provide direct communication ability as an adjunct to their primary network functions e.g. LTE-Direct or Wi-Fi Direct. Most of the short-term drivers for proximity-based services will be mobile advertising and social networking, especially friend-finder services or dating services, and gaming. In the longer term, other applications will come into play within the scope of the so called Internet of Things. The challenge and opportunity for network operators will be to develop new user scenarios and even new business models to generate revenues from these services. This research uncovers opportunities that will be both beneficial and disruptive to the existing ecosystem and value chain. This research is must reading for any company that is considering offerings within proximity and direct communications and any company that wants to stay ahead of the crowd in terms of preparation for these disruptive technologies. Target Audience: ' Mobile network operators' Industry verticals of all types' Wireless device manufacturers' Network infrastructure companies' Advertising agencies, brands, and merchants' Social networks, advertising, and content providers' Proximity, location, and direct communications vendors Key Report Benefits: ' Market forecasts for each significant technology/solution approach' Recognize the upcoming role and importance of LTE Direct compared to other solutions' Analysis of the major vendors focused on proximity and direct communications solutions' Understand the relationship between proximity, direct communications and the Internet of Things' Understand the technical and business-related differences between proximity/presence and location' Identify each of the major technologies/solutions for proximity detection, location determination, and direct communications' Evaluation of the market for major applications including public safety, social networking, advertising, the Internet of Things, and general location services Select Companies in Report: ' 3M Company' Alcatel-Lucent' iSIGN' LG' Nokia' Samsung' Qualcomm' Verizon Wireless
Competing in the European Molecular Diagnostics Market: France, Germany, Ital...ReportLinker.com
This new 970-page comprehensive five-country report from Venture Planning Group is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.
Competing in the European Clinical Chemistry and Immunodiagnostic Markets: Fr...ReportLinker.com
This document provides a summary and table of contents for a 900-page report analyzing the clinical chemistry and immunodiagnostic markets in five major European countries. The report explores trends, evaluates competitors, and identifies opportunities in these evolving markets. It contains estimates of test volumes, sales forecasts by category and country, and competitive profiles of leading suppliers.
Bradycardia Global Clinical Trials Review, H1, 2013ReportLinker.com
Bradycardia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Bradycardia Global Clinical Trials Review, H1, 2013" provides data on the Bradycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bradycardia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bradycardia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Acid Indigestion / Heartburn/ Pyrosis Global Clinical Trials Review, H1, 2013" provides data on the Acid Indigestion / Heartburn/ Pyrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acid Indigestion / Heartburn/ Pyrosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acid Indigestion / Heartburn/ Pyrosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
This document is a report on the China iron ore mining industry in 2013. It provides an overview of the industry, including its definition and development history. It analyzes the macroeconomic environment and discusses factors like policy, upstream/downstream industries. It also examines the international and domestic markets. Key data on the industry from 2008-2012 is presented, including numbers of enterprises, employees, assets, output, sales, profits and trade. The competitive landscape and strategies of major companies are evaluated. The report concludes with discussions of development trends, investment environment and new technologies in the industry.
This document provides a summary and table of contents of the "World Biomass Report" published in November 2012. The report examines the global biomass market and finds that while it suffered during the economic downturn due to low coal prices and supply issues, the sector began growing again in 2010 as coal prices rose. Most biomass plants rely on wood pellets imported from North America, though suppliers from other regions like Russia and Australia aim to compete in the market. The full report contains detailed information on biomass resources, technologies, logistics, investments and policies on a global and national level.
This report provides an overview of the global biofuels industry in 2012. It summarizes production and policies related to first, second, and third generation biofuels in countries around the world. The report finds that 2009 was a difficult year for the biofuels industry due to low oil prices and reduced demand. However, projects using diverse feedstocks or next generation technologies like cellulosics and algae continued to receive investment. The report includes sections on biofuel production trends, technologies, environmental impacts, and policies in regions like Europe, the USA, and individual European countries.
This report analyzes the current state of various renewable energy technologies including hydropower, wind, solar, biomass, biofuels, and geothermal. It examines the market size and outlook for each technology by region, discusses the advantages and disadvantages of different renewable sources, and assesses the development status and future potential of the renewable energy industry globally. The report also profiles major renewable energy companies and evaluates government policies and industry support programs around the world.
This report provides an overview of the global solar photovoltaic (PV) market. It outlines key industry data like global solar capacity, production figures, and forecasts for future growth. It also examines major country markets and discusses the advantages, challenges, and components of the solar PV industry. The report analyzes factors such as government incentives, technology developments, and manufacturing trends that are shaping the future of the solar industry.
Inguinal Hernia Global Clinical Trials Review, H1, 2013ReportLinker.com
Inguinal Hernia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Inguinal Hernia Global Clinical Trials Review, H1, 2013" provides data on the Inguinal Hernia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Inguinal Hernia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Inguinal Hernia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Cancer Cachexia Global Clinical Trials Review, H1, 2013ReportLinker.com
Cancer Cachexia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, 'Cancer Cachexia Global Clinical Trials Review, H1, 2013" provides data on the Cancer Cachexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cancer Cachexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cancer Cachexia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Pompe Disease Global Clinical Trials Review, H1, 2013ReportLinker.com
This document summarizes a report on clinical trials for Pompe disease from January 2013. It provides an overview of the number and location of trials worldwide in the first half of 2013. The US, Germany, and China had the most trials. The trials were mostly in late phases and investigated drugs from companies like Genzyme and Sanofi. The report analyzed trial trends over time and provided profiles of top trial sponsors.
Pompe Disease Global Clinical Trials Review, H1, 2013
ev3 Inc. Market Share Analysis
1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
ev3 Inc. Market Share Analysis
Published on October 2010
Report Summary
ev3 Inc. Market Share Analysis
Summary
GlobalData's new report, 'ev3 Inc. Market Share Analysis' provides in-depth information on ev3's market position in the different
medical equipment markets it operates in. The report provides ev3's market share information in two key market categories '
Interventional Neurology and Peripheral Vascular Devices. The report also provides data and information on the overall competitive
landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on
the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other
key developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house
analysis by GlobalData's team of industry experts.
Scope
- Global company shares (in Revenues) information for the key markets ev3 operates in ' Neurology Devices and Cardiovascular
Devices.
- ev3's company shares (in Revenues) information for all the key countries the company has presence in ' United States, Canada, UK,
Germany, France, Italy, Spain, Japan, China, India, and Australia.
- ev3's company shares (in Revenues) information for all the key market categories the company has presence in ' Interventional
Neurology and Peripheral Vascular Devices.
- All the key data-points are for 2009 and cover all the key regions ' North America, Europe, Asia Pacific (APAC), and Middle East and
Africa (MEA).
- Global corporate-level profile with information on the company's business segments, major products and services, competitors, and
locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value
proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any ' Mergers & Acquisitions
(M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.
Reasons to buy
- Develop sales and marketing strategies by identifying who-stands-where in the markets, ev3 operates in.
- Plan your competition strategies by identifying the company's shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are
involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in
the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not
ev3 Inc. Market Share Analysis Page 1/10
2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
limited to ev3's market positions.
Table of Content
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 13
2.1 What Is This Report About' 13
3 Definitions of Markets/Categories Covered 14
3.1 Neurology Devices 14
3.1.1 CSF Management 14
3.1.2 Interventional Neurology 14
3.1.3 Neurostimulation Devices 14
3.1.4 Neurosurgical Products 14
3.1.5 Radiosurgery 14
3.2 Cardiovascular Devices 14
3.2.1 Cardiac Assist Devices 15
3.2.2 Cardiac Rhythm Management 15
3.2.3 Cardiovascular Monitoring and Diagnostic Devices 15
3.2.4 Cardiovascular Prosthetic Devices 15
3.2.5 Cardiovascular Surgery 15
3.2.6 Electrophysiology 15
3.2.7 External Defibrillator 16
3.2.8 Interventional Cardiology 16
3.2.9 Peripheral Vascular Devices 16
3.2.10 Prosthetic Heart Valve 16
4 Company Snapshot 17
4.1 Key Information 17
4.2 Company Overview 17
4.3 Financial Performance 17
4.4 SWOT Snapshot 17
5 Business Description 18
5.1 Business Overview 18
5.2 Neurovascular Segment 18
5.2.1 Overview 18
5.2.2 Financials 18
5.2.3 Market View 18
5.2.4 Key Strategies 19
5.3 Peripheral Vascular Segment 19
5.3.1 Overview 19
5.3.2 Financials 19
5.3.3 Market View 19
5.3.4 Key Strategies 19
5.4 Major Products and Services 20
5.4.1 Overview 20
6 History 22
7 SWOT Analysis 24
ev3 Inc. Market Share Analysis Page 2/10
3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
7.1 Overview 24
7.2 ev3 Inc. Strengths 24
7.2.1 Sturdy Research Activities 24
7.2.2 Expanding Market Share in the Sector 25
7.2.3 Diversified Endovascular Product Portfolio 25
7.2.4 Expanding Operating Margin 25
7.2.5 Efficient Use of Resources 26
7.2.6 Strong Growth Prospects 26
7.3 ev3 Inc. Weaknesses 26
7.3.1 Principal Manufacturing Facility 26
7.3.2 Product Recalls 26
7.3.3 Decreased Demand for Plaque Excision Products 26
7.4 ev3 Inc. Opportunities 27
7.4.1 Market Growth in Emerging Economies 27
7.4.2 Growing Aged Population 27
7.4.3 Growing Market 27
7.4.4 Robust Pipeline Products 27
7.4.5 Strategic Acquisitions 27
7.5 ev3 Inc. Threats 28
7.5.1 Cost Containment Pressures 28
7.5.2 Industry Consolidation Challenges 28
7.5.3 Competition 28
7.5.4 Technological Changes 28
7.5.5 Stringent Government Regulations 29
8 Competitors 30
9 Competitive Landscape 31
9.1 Neurology Devices, Global, Company Share (%), 2009 31
9.2 Cardiovascular Devices, Global, Company Share (%), 2009 33
10 ev3 Inc. Medical Equipment Market Share Analysis 35
10.1 ev3 Inc., Global, Market Share (2009) 35
10.2 ev3 Inc., Asia-Pacific, Market Share (2009) 37
10.2.1 ev3 Inc., Australia, Market Share (2009) 39
10.2.2 ev3 Inc., China, Market Share (2009) 41
10.2.3 ev3 Inc., India, Market Share (2009) 43
10.2.4 ev3 Inc., Japan, Market Share (2009) 45
10.2.5 ev3 Inc., Other Asia-Pacific, Market Share (2009) 47
10.3 ev3 Inc., Europe, Market Share (2009) 49
10.3.1 ev3 Inc., France, Market Share (2009) 51
10.3.2 ev3 Inc., Germany, Market Share (2009) 53
10.3.3 ev3 Inc., Italy, Market Share (2009) 55
10.3.4 ev3 Inc., Spain, Market Share (2009) 57
10.3.5 ev3 Inc., United Kingdom, Market Share (2009) 59
10.3.6 ev3 Inc., Other Europe, Market Share (2009) 61
10.4 ev3 Inc., Middle East and Africa, Market Share (2009) 63
10.5 ev3 Inc., North America, Market Share (2009) 64
10.5.1 ev3 Inc., Canada, Market Share (2009) 66
10.5.2 ev3 Inc., United States, Market Share (2009) 68
10.6 ev3 Inc., South and Central America, Market Share (2009) 70
10.6.1 ev3 Inc., Brazil, Market Share (2009) 72
10.6.2 ev3 Inc., Other South and Central America, Market Share (2009) 74
ev3 Inc. Market Share Analysis Page 3/10
4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
11 ev3 Inc. Medical Equipment Market Share Analysis by Category 76
11.1 ev3 Inc., Global, Category Revenue Share (2009) 76
11.2 ev3 Inc., Asia-Pacific, Category Revenue Share (2009) 78
11.2.1 ev3 Inc., Australia, Category Revenue Share (2009) 80
11.2.2 ev3 Inc., China, Category Revenue Share (2009) 82
11.2.3 ev3 Inc., India, Category Revenue Share (2009) 84
11.2.4 ev3 Inc., Japan, Category Revenue Share (2009) 86
11.2.5 ev3 Inc., Other Asia-Pacific, Category Revenue Share (2009) 88
11.3 ev3 Inc., Europe, Category Revenue Share (2009) 90
11.3.1 ev3 Inc., France, Category Revenue Share (2009) 92
11.3.2 ev3 Inc., Germany, Category Revenue Share (2009) 94
11.3.3 ev3 Inc., Italy, Category Revenue Share (2009) 96
11.3.4 ev3 Inc., Spain, Category Revenue Share (2009) 98
11.3.5 ev3 Inc., United Kingdom, Category Revenue Share (2009) 100
11.3.6 ev3 Inc., Other Europe, Category Revenue Share (2009) 102
11.4 ev3 Inc., Middle East and Africa, Category Revenue Share (2009) 104
11.5 ev3 Inc., North America, Category Revenue Share (2009) 105
11.5.1 ev3 Inc., Canada, Category Revenue Share (2009) 107
11.5.2 ev3 Inc., United States, Category Revenue Share (2009) 109
11.6 ev3 Inc., South and Central America, Category Revenue Share (2009) 111
11.6.1 ev3 Inc., Brazil, Category Revenue Share (2009) 113
11.6.2 ev3 Inc., Other South and Central America, Category Revenue Share (2009) 115
12 Key Employees 117
13 Key Employee Biographies 118
14 Company Statement 120
15 Locations And Subsidiaries 123
15.1 Head Office 123
15.2 Other Locations & Subsidiaries 123
16 Financial Deals Landscape 125
16.1 ev3 Inc., Deals Volume Summary, 2005 to YTD 2010 125
17 ev3 Inc. Detailed Deal Summary 127
17.1 Venture Financing 127
17.1.1 Chestnut Medical Technologies Secures $7.8 Million In Venture Financing 127
17.1.2 Chestnut Medical Technologies Secures $0.83 Million In Series B Financing 128
17.2 Partnerships 129
17.2.1 ev3 Terminates Agreement With Bacchus Vascular 129
17.2.2 ev3 Enters Into Distribution Agreement With Lepu 130
17.2.3 Volcano Signs An Agreement With ev3 131
17.2.4 ev3 And Foxhollow Enter Into Distribution Agreement 132
17.2.5 ev3 Enters Into An Agreement With Invatec 133
17.3 Equity Offering 134
17.3.1 ev3 Completes Public Offering Of $47.5 Million 134
17.3.2 ev3 Completes Initial Public Offering Of $164.71 Million 136
17.3.3 FoxHollow Technologies Completes Initial Public Offering Of $72.45 Million 137
17.4 Divestiture - Assets 139
17.4.1 Atritech Completes Acquisition Of Intellectual Property From ev3 Endovascular 139
17.5 Acquisition 141
17.5.1 Covidien Completes Acquisition Of ev3 For $2.6 Billion 141
17.5.2 ev3 Completes Acquisition Of Chestnut Medical Technologies 143
17.5.3 ev3 Acquires Foxhollow Technologies 145
ev3 Inc. Market Share Analysis Page 4/10
5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
17.5.4 Merck & Co. Acquires 11% Stake In FoxHollow Technologies 147
17.5.5 Foxhollow Technologies Acquires Kerberos Proximal Solutions 148
17.5.6 ev3 Acquires Micro Therapeutics 150
18 Appendix 151
18.1 Research Methodology 152
18.2 Secondary Research 152
18.3 Primary Research 153
18.4 Models 153
18.5 Forecasts 154
18.6 Expert Panels 154
18.7 GlobalData Consulting 154
18.8 Currency Conversion 155
18.9 Contact Us 156
18.10 Disclaimer 156
1.1 List of Tables
Table 1: ev3 Inc., Key Facts, 2009 17
Table 2: ev3 Inc., SWOT Analysis, 2009 24
Table 3: Neurology Devices, Global, Company Share by Revenue ($m), 2009 32
Table 4: Cardiovascular Devices, Global, Company Share by Revenue ($m), 2009 34
Table 5: ev3 Inc., Medical Equipment, Global, Revenue ($m) and Market Share (%), 2009 36
Table 6: ev3 Inc., Medical Equipment, Asia-Pacific, Revenue ($m) and Market Share (%), 2009 38
Table 7: ev3 Inc., Medical Equipment, Australia, Revenue ($m) and Market Share (%), 2009 40
Table 8: ev3 Inc., Medical Equipment, China, Revenue ($m) and Market Share (%), 2009 42
Table 9: ev3 Inc., Medical Equipment, India, Revenue ($m) and Market Share (%), 2009 44
Table 10: ev3 Inc., Medical Equipment, Japan, Revenue ($m) and Market Share (%), 2009 46
Table 11: ev3 Inc., Medical Equipment, Other Asia-Pacific, Revenue ($m) and Market Share (%), 2009 48
Table 12: ev3 Inc., Medical Equipment, Europe, Revenue ($m) and Market Share (%), 2009 50
Table 13: ev3 Inc., Medical Equipment, France, Revenue ($m) and Market Share (%), 2009 52
Table 14: ev3 Inc., Medical Equipment, Germany, Revenue ($m) and Market Share (%), 2009 54
Table 15: ev3 Inc., Medical Equipment, Italy, Revenue ($m) and Market Share (%), 2009 56
Table 16: ev3 Inc., Medical Equipment, Spain, Revenue ($m) and Market Share (%), 2009 58
Table 17: ev3 Inc., Medical Equipment, United Kingdom, Revenue ($m) and Market Share (%), 2009 60
Table 18: ev3 Inc., Medical Equipment, Other Europe, Revenue ($m) and Market Share (%), 2009 62
Table 19: ev3 Inc., Medical Equipment, Middle East and Africa, Revenue ($m) and Market Share (%), 2009 63
Table 20: ev3 Inc., Medical Equipment, North America, Revenue ($m) and Market Share (%), 2009 65
Table 21: ev3 Inc., Medical Equipment, Canada, Revenue ($m) and Market Share (%), 2009 67
Table 22: ev3 Inc., Medical Equipment, United States, Revenue ($m) and Market Share (%), 2009 69
Table 23: ev3 Inc., Medical Equipment, South and Central America, Revenue ($m) and Market Share (%), 2009 71
Table 24: ev3 Inc., Medical Equipment, Brazil, Revenue ($m) and Market Share (%), 2009 73
Table 25: ev3 Inc., Medical Equipment, Other South and Central America, Revenue ($m) and Market Share (%), 2009 75
Table 26: ev3 Inc., Medical Equipment, Global, Revenue ($m) and Market Share (%) by Category, 2009 77
Table 27: ev3 Inc., Medical Equipment, Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2009 79
Table 28: ev3 Inc., Medical Equipment, Australia, Revenue ($m) and Market Share (%) by Category, 2009 81
Table 29: ev3 Inc., Medical Equipment, China, Revenue ($m) and Market Share (%) by Category, 2009 83
Table 30: ev3 Inc., Medical Equipment, India, Revenue ($m) and Market Share (%) by Category, 2009 85
Table 31: ev3 Inc., Medical Equipment, Japan, Revenue ($m) and Market Share (%) by Category, 2009 87
Table 32: ev3 Inc., Medical Equipment, Other Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2009 89
Table 33: ev3 Inc., Medical Equipment, Europe, Revenue ($m) and Market Share (%) by Category, 2009 91
Table 34: ev3 Inc., Medical Equipment, France, Revenue ($m) and Market Share (%) by Category, 2009 93
ev3 Inc. Market Share Analysis Page 5/10
6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table 35: ev3 Inc., Medical Equipment, Germany, Revenue ($m) and Market Share (%) by Category, 2009 95
Table 36: ev3 Inc., Medical Equipment, Italy, Revenue ($m) and Market Share (%) by Category, 2009 97
Table 37: ev3 Inc., Medical Equipment, Spain, Revenue ($m) and Market Share (%) by Category, 2009 99
Table 38: ev3 Inc., Medical Equipment, United Kingdom, Revenue ($m) and Market Share (%) by Category, 2009 101
Table 39: ev3 Inc., Medical Equipment, Other Europe, Revenue ($m) and Market Share (%) by Category, 2009 103
Table 40: ev3 Inc., Medical Equipment, Middle East and Africa, Revenue ($m) and Market Share (%) by Category, 2009 104
Table 41: ev3 Inc., Medical Equipment, North America, Revenue ($m) and Market Share (%) by Category, 2009 106
Table 42: ev3 Inc., Medical Equipment, Canada, Revenue ($m) and Market Share (%) by Category, 2009 108
Table 43: ev3 Inc., Medical Equipment, United States, Revenue ($m) and Market Share (%) by Category, 2009 110
Table 44: ev3 Inc., Medical Equipment, South and Central America, Revenue ($m) and Market Share (%) by Category, 2009 112
Table 45: ev3 Inc., Medical Equipment, Brazil, Revenue ($m) and Market Share (%) by Category, 2009 114
Table 46: ev3 Inc., Medical Equipment, Other South and Central America, Revenue ($m) and Market Share (%) by Category,
2009 116
Table 47: ev3 Inc., Key Employees 117
Table 48: ev3 Inc., Other Locations 123
Table 49: ev3 Inc., Subsidiaries 124
Table 50: ev3 Inc., Deals Volume Summary, 2005 to YTD 2010 125
Table 51: ev3 Inc., Deals Summary, 2005 to YTD 2010 126
Table 52: Chestnut Medical Technologies Secures $7.8 Million In Venture Financing 127
Table 53: Chestnut Medical Technologies Secures $0.83 Million In Series B Financing 128
Table 54: ev3 Terminates Agreement With Bacchus Vascular 129
Table 55: ev3 Enters Into Distribution Agreement With Lepu 130
Table 56: Volcano Signs An Agreement With ev3 131
Table 57: ev3 And Foxhollow Enter Into Distribution Agreement 132
Table 58: ev3 Enters Into An Agreement With Invatec 133
Table 59: ev3 Completes Public Offering Of $47.5 Million 134
Table 60: ev3 Completes Initial Public Offering Of $164.71 Million 136
Table 61: FoxHollow Technologies Completes Initial Public Offering Of $72.45 Million 137
Table 62: Atritech Completes Acquisition Of Intellectual Property From ev3 Endovascular 139
Table 63: Covidien Completes Acquisition Of ev3 For $2.6 Billion 141
Table 64: ev3 Completes Acquisition Of Chestnut Medical Technologies 143
Table 65: ev3 Acquires Foxhollow Technologies 145
Table 66: Merck & Co. Acquires 11% Stake In FoxHollow Technologies 147
Table 67: Foxhollow Technologies Acquires Kerberos Proximal Solutions 148
Table 68: ev3 Acquires Micro Therapeutics 150
Table 69: USD to Local Currency, Average Exchange Rate 2009 155
1.2 List of Figures
Figure 1: Neurology Devices, Global, Company Share (%), 2009 31
Figure 2: Cardiovascular Devices, Global, Company Share (%), 2009 33
Figure 3: ev3 Inc., Medical Equipment, Global, Revenue Share (%), 2009 35
Figure 4: ev3 Inc., Medical Equipment, Global, Market Share (%), 2009 36
Figure 5: ev3 Inc., Medical Equipment, Asia-Pacific, Revenue Share (%), 2009 37
Figure 6: ev3 Inc., Medical Equipment, Asia-Pacific, Market Share (%), 2009 38
Figure 7: ev3 Inc., Medical Equipment, Australia, Revenue Share (%), 2009 39
Figure 8: ev3 Inc., Medical Equipment, Australia, Market Share (%), 2009 40
Figure 9: ev3 Inc., Medical Equipment, China, Revenue Share (%), 2009 41
Figure 10: ev3 Inc., Medical Equipment, China, Market Share (%), 2009 42
Figure 11: ev3 Inc., Medical Equipment, India, Revenue Share (%), 2009 43
Figure 12: ev3 Inc., Medical Equipment, India, Market Share (%), 2009 44
ev3 Inc. Market Share Analysis Page 6/10
7. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Figure 13: ev3 Inc., Medical Equipment, Japan, Revenue Share (%), 2009 45
Figure 14: ev3 Inc., Medical Equipment, Japan, Market Share (%), 2009 46
Figure 15: ev3 Inc., Medical Equipment, Other Asia-Pacific, Revenue Share (%), 2009 47
Figure 16: ev3 Inc., Medical Equipment, Other Asia-Pacific, Market Share (%), 2009 48
Figure 17: ev3 Inc., Medical Equipment, Europe, Revenue Share (%), 2009 49
Figure 18: ev3 Inc., Medical Equipment, Europe, Market Share (%), 2009 50
Figure 19: ev3 Inc., Medical Equipment, France, Revenue Share (%), 2009 51
Figure 20: ev3 Inc., Medical Equipment, France, Market Share (%), 2009 52
Figure 21: ev3 Inc., Medical Equipment, Germany, Revenue Share (%), 2009 53
Figure 22: ev3 Inc., Medical Equipment, Germany, Market Share (%), 2009 54
Figure 23: ev3 Inc., Medical Equipment, Italy, Revenue Share (%), 2009 55
Figure 24: ev3 Inc., Medical Equipment, Italy, Market Share (%), 2009 56
Figure 25: ev3 Inc., Medical Equipment, Spain, Revenue Share (%), 2009 57
Figure 26: ev3 Inc., Medical Equipment, Spain, Market Share (%), 2009 58
Figure 27: ev3 Inc., Medical Equipment, United Kingdom, Revenue Share (%), 2009 59
Figure 28: ev3 Inc., Medical Equipment, United Kingdom, Market Share (%), 2009 60
Figure 29: ev3 Inc., Medical Equipment, Other Europe, Revenue Share (%), 2009 61
Figure 30: ev3 Inc., Medical Equipment, Other Europe, Market Share (%), 2009 62
Figure 31: ev3 Inc., Medical Equipment, North America, Revenue Share (%), 2009 64
Figure 32: ev3 Inc., Medical Equipment, North America, Market Share (%), 2009 65
Figure 33: ev3 Inc., Medical Equipment, Canada, Revenue Share (%), 2009 66
Figure 34: ev3 Inc., Medical Equipment, Canada, Market Share (%), 2009 67
Figure 35: ev3 Inc., Medical Equipment, United States, Revenue Share (%), 2009 68
Figure 36: ev3 Inc., Medical Equipment, United States, Market Share (%), 2009 69
Figure 37: ev3 Inc., Medical Equipment, South and Central America, Revenue Share (%), 2009 70
Figure 38: ev3 Inc., Medical Equipment, South and Central America, Market Share (%), 2009 71
Figure 39: ev3 Inc., Medical Equipment, Brazil, Revenue Share (%), 2009 72
Figure 40: ev3 Inc., Medical Equipment, Brazil, Market Share (%), 2009 73
Figure 41: ev3 Inc., Medical Equipment, Other South and Central America, Revenue Share (%), 2009 74
Figure 42: ev3 Inc., Medical Equipment, Other South and Central America, Market Share (%), 2009 75
Figure 43: ev3 Inc., Medical Equipment, Global, Category Revenue Share (%), 2009 76
Figure 44: ev3 Inc., Medical Equipment, Global, Market Share (%) by Category, 2009 77
Figure 45: ev3 Inc., Medical Equipment, Asia-Pacific, Category Revenue Share (%), 2009 78
Figure 46: ev3 Inc., Medical Equipment, Asia-Pacific, Market Share (%) by Category, 2009 79
Figure 47: ev3 Inc., Medical Equipment, Australia, Category Revenue Share (%), 2009 80
Figure 48: ev3 Inc., Medical Equipment, Australia, Market Share (%) by Category, 2009 81
Figure 49: ev3 Inc., Medical Equipment, China, Category Revenue Share (%), 2009 82
Figure 50: ev3 Inc., Medical Equipment, China, Market Share (%) by Category, 2009 83
Figure 51: ev3 Inc., Medical Equipment, India, Category Revenue Share (%), 2009 84
Figure 52: ev3 Inc., Medical Equipment, India, Market Share (%) by Category, 2009 85
Figure 53: ev3 Inc., Medical Equipment, Japan, Category Revenue Share (%), 2009 86
Figure 54: ev3 Inc., Medical Equipment, Japan, Market Share (%) by Category, 2009 87
Figure 55: ev3 Inc., Medical Equipment, Other Asia-Pacific, Category Revenue Share (%), 2009 88
Figure 56: ev3 Inc., Medical Equipment, Other Asia-Pacific, Market Share (%) by Category, 2009 89
Figure 57: ev3 Inc., Medical Equipment, Europe, Category Revenue Share (%), 2009 90
Figure 58: ev3 Inc., Medical Equipment, Europe, Market Share (%) by Category, 2009 91
Figure 59: ev3 Inc., Medical Equipment, France, Category Revenue Share (%), 2009 92
Figure 60: ev3 Inc., Medical Equipment, France, Market Share (%) by Category, 2009 93
Figure 61: ev3 Inc., Medical Equipment, Germany, Category Revenue Share (%), 2009 94
Figure 62: ev3 Inc., Medical Equipment, Germany, Market Share (%) by Category, 2009 95
ev3 Inc. Market Share Analysis Page 7/10
8. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Figure 63: ev3 Inc., Medical Equipment, Italy, Category Revenue Share (%), 2009 96
Figure 64: ev3 Inc., Medical Equipment, Italy, Market Share (%) by Category, 2009 97
Figure 65: ev3 Inc., Medical Equipment, Spain, Category Revenue Share (%), 2009 98
Figure 66: ev3 Inc., Medical Equipment, Spain, Market Share (%) by Category, 2009 99
Figure 67: ev3 Inc., Medical Equipment, United Kingdom, Category Revenue Share (%), 2009 100
Figure 68: ev3 Inc., Medical Equipment, United Kingdom, Market Share (%) by Category, 2009 101
Figure 69: ev3 Inc., Medical Equipment, Other Europe, Category Revenue Share (%), 2009 102
Figure 70: ev3 Inc., Medical Equipment, Other Europe, Market Share (%) by Category, 2009 103
Figure 71: ev3 Inc., Medical Equipment, North America, Category Revenue Share (%), 2009 105
Figure 72: ev3 Inc., Medical Equipment, North America, Market Share (%) by Category, 2009 106
Figure 73: ev3 Inc., Medical Equipment, Canada, Category Revenue Share (%), 2009 107
Figure 74: ev3 Inc., Medical Equipment, Canada, Market Share (%) by Category, 2009 108
Figure 75: ev3 Inc., Medical Equipment, United States, Category Revenue Share (%), 2009 109
Figure 76: ev3 Inc., Medical Equipment, United States, Market Share (%) by Category, 2009 110
Figure 77: ev3 Inc., Medical Equipment, South and Central America, Category Revenue Share (%), 2009 111
Figure 78: ev3 Inc., Medical Equipment, South and Central America, Market Share (%) by Category, 2009 112
Figure 79: ev3 Inc., Medical Equipment, Brazil, Category Revenue Share (%), 2009 113
Figure 80: ev3 Inc., Medical Equipment, Brazil, Market Share (%) by Category, 2009 114
Figure 81: ev3 Inc., Medical Equipment, Other South and Central America, Category Revenue Share (%), 2009 115
Figure 82: ev3 Inc., Medical Equipment, Other South and Central America, Market Share (%) by Category, 2009 116
Figure 83: ev3 Inc., Deals Volume Summary, 2005 to YTD 2010 125
Companies mentioned
Abbott Laboratories
Accuray Incorporated
B. Braun Melsungen AG
Balt Extrusion
Biosense Webster, Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
C.R. Bard, Inc.
Cardiovascular Systems, Inc.
Cook Group Incorporated
Cordis Corporation
Cyberonics, Inc.
Edwards Lifesciences Corporation
Elekta AB
IDev Technologies, Inc.
MEDRAD, Inc.
Medtronic, Inc.
Micrus Endovascular Corporation
Pathway Medical Technologies, Inc.
Philips Healthcare
Sorin Group
St. Jude Medical, Inc.
Terumo Corporation
The Spectranetics Corporation
Thoratec Corporation
ZOLL Medical Corporation
ev3 Inc. Market Share Analysis Page 8/10
9. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
ev3 Inc. Market Share Analysis
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 000.00 Quantity: _____
Site License--USD 2 000.00 Quantity: _____
Corporate License--USD 3 000.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
ev3 Inc. Market Share Analysis Page 9/10
10. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
ev3 Inc. Market Share Analysis Page 10/10